ACTRN12605000577617已完成4 期
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical neuroleptics: A double-blind, randomised, placebo controlled trial
niversity of Melbourne0 个研究点目标入组 40 人开始时间: 2005年10月4日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Diagnosis of schizophrenia confirmed by the Mini International Neuropsychiatric Interview (MINI).Currently being treated with an atypical antipsychotic.
排除标准
- •Patients with significant medical illnesses and patients on any other psychotropic agents except benzodiazepines, patients who have a history of any other major psychiatric disorder, and patients meeting criteria for substance abuse or who regularly consume over 3 alcoholic drinks daily, pregnancy.
研究者
相似试验
尚未招募
Unknown
A comparative clinical experiment of mirtazapine and amitriptyline in India on patients with recurring symptoms of an upset stomach that have no obvious causeCTRI/2024/01/061596Indian Council of Medical Research (ICMR)
进行中（未招募）
1 期
A randomised placebo controlled trial in which mirtazapine, an antidepressant, is added for patients with depression in primary care who have not responded to treatment with first-line antidepressants.Treatment resistant depressionMedDRA version: 16.0Level: LLTClassification code 10045543Term: Unipolar depressionSystem Organ Class: 100000004873EUCTR2012-000090-23-GBniversity of Bristol470
进行中（未招募）
1 期
Evaluation of Mirtazapine and Folic Acid for Schizophrenia:A Large Simple 2x2 Factorial Trial.Schizophorenia with suboptimal responce to standard antipsychotics.EUCTR2009-014469-19-FIOxford University53
已完成
不适用
Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phaseSchizophreniaISRCTN00721331Stanley Medical Research Institute (USA)40
进行中（未招募）
1 期
Add-on spironolactone for the treatment of schizophreniaMedDRA version: 21.1Level: LLTClassification code 10039643Term: Schizophrenic psychosesSystem Organ Class: 100000004873SchizophreniaEUCTR2014-001968-35-DEKlinikum der Universität München - AöR vertreten durch den Vorstand des Bereiches umanmedizinH90